Bin Gu1,2, John R Shorter3,4,5,6, Lucy H Williams3, Timothy A Bell3,7, Pablo Hock3,7, Katherine A Dalton8, Yiyun Pan8, Darla R Miller3,7, Ginger D Shaw3,7, Benjamin D Philpot1,2,4,8, Fernando Pardo-Manuel de Villena3,4,7. 1. Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC, USA. 2. Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA. 3. Department of Genetics, University of North Carolina, Chapel Hill, NC, USA. 4. Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA. 5. Institute of Biological Psychiatry, Mental Health Centre Sct. Hans, Mental Health Services, Copenhagen, Denmark. 6. iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark. 7. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. 8. Neuroscience Curriculum, University of North Carolina, Chapel Hill, NC, USA.
Abstract
OBJECTIVE: Animal studies remain essential for understanding mechanisms of epilepsy and identifying new therapeutic targets. However, existing animal models of epilepsy do not reflect the high level of genetic diversity found in the human population. The Collaborative Cross (CC) population is a genetically diverse recombinant inbred panel of mice. The CC offers large genotypic and phenotypic diversity, inbred strains with stable genomes that allow for repeated phenotypic measurements, and genomic tools including whole genome sequence to identify candidate genes and candidate variants. METHODS: We evaluated multiple complex epileptic traits in a sampling of 35 CC inbred strains using the flurothyl-induced seizure and kindling paradigm. We created an F2 population of 297 mice with extreme seizure susceptibility and performed quantitative trait loci (QTL) mapping to identify genomic regions associated with seizure sensitivity. We used quantitative RNA sequencing from CC hippocampal tissue to identify candidate genes and whole genome sequence to identify genetic variants likely affecting gene expression. RESULTS: We identified new mouse models with extreme seizure susceptibility, seizure propagation, epileptogenesis, and SUDEP (sudden unexpected death in epilepsy). We performed QTL mapping and identified one known and seven novel loci associated with seizure sensitivity. We combined whole genome sequencing and hippocampal gene expression to pinpoint biologically plausible candidate genes (eg, Gabra2) and variants associated with seizure sensitivity. SIGNIFICANCE: New mouse models of epilepsy are needed to better understand the complex genetic architecture of seizures and to identify therapeutics. We performed a phenotypic screen utilizing a novel genetic reference population of CC mice. The data we provide enable the identification of protective/risk genes and novel molecular mechanisms linked to complex seizure traits that are currently challenging to study and treat.
OBJECTIVE: Animal studies remain essential for understanding mechanisms of epilepsy and identifying new therapeutic targets. However, existing animal models of epilepsy do not reflect the high level of genetic diversity found in the human population. The Collaborative Cross (CC) population is a genetically diverse recombinant inbred panel of mice. The CC offers large genotypic and phenotypic diversity, inbred strains with stable genomes that allow for repeated phenotypic measurements, and genomic tools including whole genome sequence to identify candidate genes and candidate variants. METHODS: We evaluated multiple complex epileptic traits in a sampling of 35 CC inbred strains using the flurothyl-induced seizure and kindling paradigm. We created an F2 population of 297 mice with extreme seizure susceptibility and performed quantitative trait loci (QTL) mapping to identify genomic regions associated with seizure sensitivity. We used quantitative RNA sequencing from CC hippocampal tissue to identify candidate genes and whole genome sequence to identify genetic variants likely affecting gene expression. RESULTS: We identified new mouse models with extreme seizure susceptibility, seizure propagation, epileptogenesis, and SUDEP (sudden unexpected death in epilepsy). We performed QTL mapping and identified one known and seven novel loci associated with seizure sensitivity. We combined whole genome sequencing and hippocampal gene expression to pinpoint biologically plausible candidate genes (eg, Gabra2) and variants associated with seizure sensitivity. SIGNIFICANCE: New mouse models of epilepsy are needed to better understand the complex genetic architecture of seizures and to identify therapeutics. We performed a phenotypic screen utilizing a novel genetic reference population of CC mice. The data we provide enable the identification of protective/risk genes and novel molecular mechanisms linked to complex seizure traits that are currently challenging to study and treat.
Authors: Toshihiro Nomura; Nicole A Hawkins; Jennifer A Kearney; Alfred L George; Anis Contractor Journal: J Physiol Date: 2019-05-20 Impact factor: 5.182
Authors: Dominick Papandrea; Whitney S Kukol; Tara M Anderson; Bruce J Herron; Russell J Ferland Journal: Epilepsy Res Date: 2009-09-09 Impact factor: 3.045
Authors: Anna J Nathanson; Yihui Zhang; Joshua L Smalley; Thomas A Ollerhead; Miguel A Rodriguez Santos; Peter M Andrews; Heike J Wobst; Yvonne E Moore; Nicholas J Brandon; Rochelle M Hines; Paul A Davies; Stephen J Moss Journal: Cell Rep Date: 2019-07-16 Impact factor: 9.423
Authors: Remco T Molenhuis; Hilgo Bruining; Myrna J V Brandt; Petra E van Soldt; Hanifa J Abu-Toamih Atamni; J Peter H Burbach; Fuad A Iraqi; Richard F Mott; Martien J H Kas Journal: Mol Autism Date: 2018-12-13 Impact factor: 7.509
Authors: Megan K Mulligan; Timothy Abreo; Sarah M Neuner; Cory Parks; Christine E Watkins; M Trevor Houseal; Thomas M Shapaker; Michael Hook; Haiyan Tan; Xusheng Wang; Jesse Ingels; Junmin Peng; Lu Lu; Catherine C Kaczorowski; Camron D Bryant; Gregg E Homanics; Robert W Williams Journal: Front Genet Date: 2019-03-29 Impact factor: 4.599
Authors: Jennifer A Kearney; Letonia D Copeland-Hardin; Samantha Duarte; Nicole A Zachwieja; Isaiah K Eckart-Frank; Nicole A Hawkins Journal: Mamm Genome Date: 2022-05-23 Impact factor: 3.224
Authors: Bin Gu; Noah G Levine; Wenjing Xu; Rachel M Lynch; Fernando Pardo-Manuel de Villena; Benjamin D Philpot Journal: Brain Commun Date: 2022-03-25
Authors: John Sebastian Sigmon; Matthew W Blanchard; Ralph S Baric; Timothy A Bell; Jennifer Brennan; Gudrun A Brockmann; A Wesley Burks; J Mauro Calabrese; Kathleen M Caron; Richard E Cheney; Dominic Ciavatta; Frank Conlon; David B Darr; James Faber; Craig Franklin; Timothy R Gershon; Lisa Gralinski; Bin Gu; Christiann H Gaines; Robert S Hagan; Ernest G Heimsath; Mark T Heise; Pablo Hock; Folami Ideraabdullah; J Charles Jennette; Tal Kafri; Anwica Kashfeen; Mike Kulis; Vivek Kumar; Colton Linnertz; Alessandra Livraghi-Butrico; K C Kent Lloyd; Cathleen Lutz; Rachel M Lynch; Terry Magnuson; Glenn K Matsushima; Rachel McMullan; Darla R Miller; Karen L Mohlke; Sheryl S Moy; Caroline E Y Murphy; Maya Najarian; Lori O'Brien; Abraham A Palmer; Benjamin D Philpot; Scott H Randell; Laura Reinholdt; Yuyu Ren; Steve Rockwood; Allison R Rogala; Avani Saraswatula; Christopher M Sassetti; Jonathan C Schisler; Sarah A Schoenrock; Ginger D Shaw; John R Shorter; Clare M Smith; Celine L St Pierre; Lisa M Tarantino; David W Threadgill; William Valdar; Barbara J Vilen; Keegan Wardwell; Jason K Whitmire; Lucy Williams; Mark J Zylka; Martin T Ferris; Leonard McMillan; Fernando Pardo Manuel de Villena Journal: Genetics Date: 2020-10-16 Impact factor: 4.402
Authors: Wenxi Yu; Sophie F Hill; James G Xenakis; Fernando Pardo-Manuel de Villena; Jacy L Wagnon; Miriam H Meisler Journal: Epilepsia Date: 2020-11-02 Impact factor: 5.864
Authors: Perry W E Spratt; Ryan P D Alexander; Roy Ben-Shalom; Atehsa Sahagun; Henry Kyoung; Caroline M Keeshen; Stephan J Sanders; Kevin J Bender Journal: Cell Rep Date: 2021-08-03 Impact factor: 9.423